Education
About Us
Working with TipRanks
Follow Us
Microbot Medical Inc (MBOT)
NASDAQ:MBOT
Total Valuation
Microbot Medical has a market cap or net worth of $77.48M. The enterprise value is .
Market Cap$77.48M
Enterprise Value
Share Statistics
Microbot Medical has 34.74M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34.74M
Owened by Insiders0.39%
Owened by Instutions0.64%
Financial Efficiency
Microbot Medical’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)5.16%
Return on Assets (ROA)3.02%
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00%
Revenue Per Employee$0
Profits Per Employee-$572,150
Employee Count20
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Microbot Medical is 96.27. Microbot Medical’s PEG ratio is -0.95.
PE Ratio96.27
PS Ratio0.00
PB Ratio4.96
Price to Fair Value4.96
Price to FCF-1.98
Price to Operating Cash Flow-1.99
PEG Ratio-0.95
Income Statement
In the last 12 months, Microbot Medical had revenue of $0.00 and earned -$11.44M in profits. Earnings per share was -$0.76.
Revenue$0.00
Gross Profit-$42.00K
Operating Income-$11.63M
Pretax Income-$11.44M
Net Income-$11.44M
EBITDA-11.53M
Earnings Per Share (EPS)-0.76
Cash Flow
In the last 12 months, operating cash flow was -$8.83M and capital expenditures -$25.00K, giving a free cash flow of -$8.85M billion.
Operating Cash Flow-$8.83M
Free Cash Flow-$8.85M
Free Cash Flow per Share-$0.25
Dividends & Yields
Microbot Medical pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-50.52%
Earnings Yield1.04%
Stock Price Statistics
Beta1.94
52-Week Price Change116.50%
50-Day Moving Average1.69
200-Day Moving Average1.24
Relative Strength Index (RSI)44.53
Average Volume (3m)2.57M
Important Dates
Microbot Medical upcoming earnings date is Mar 31, 2021, TBA.
Last Earnings DateApr 14, 2020
Next Earnings DateMar 31, 2021
Ex-Dividend Date―
Financial Position
Microbot Medical as a current ratio of 2.37, with Debt / Equity ratio of 0.03
Current Ratio2.37
Quick Ratio2.37
Debt to Market Cap<0.01
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Microbot Medical has paid -$15.28K in taxes.
Income Tax-$15.28K
Effective Tax Rate100.00%
Enterprise Valuation
Microbot Medical EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -1.64.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow-1.64
EV to Operating Cash Flow-1.64
Balance Sheet
Microbot Medical has $5.47M in cash and marketable securities with $111.00K in debt, giving a net cash position of -$5.36M billion.
Cash & Marketable Securities$5.47M
Total Debt$111.00K
Net Cash-$5.36M
Net Cash Per Share-$0.15
Tangible Book Value Per Share$0.23
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Microbot Medical is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.00
Price Target Upside303.59%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast